Solid Lipid–PEI Hybrid Nanocarrier: An Integrated Approach To Provide Extended, Targeted, and Safer siRNA Therapy of Prostate Cancer in an All-in-One Manner-Reference-Cited by-同舟云学术

Solid Lipid–PEI Hybrid Nanocarrier: An Integrated Approach To Provide Extended, Targeted, and Safer siRNA Therapy of Prostate Cancer in an All-in-One Manner

Published:2011-08-18 Issue:9 Volume:5 Page:7034-7047
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Xue Hui-Yi¹,Wong Ho-Lun¹

Affiliation:

1. Department of Pharmaceutical Sciences, Temple University School of Pharmacy, 3307 North Broad Street, Philadelphia, Pennsylvania 19140, United States

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/nn201659z

Reference53 articles.

1. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

2. Revealing the world of RNA interference

3. Targeted Delivery of Small Interfering RNA: Approaching Effective Cancer Therapies: Figure 1.

4. Gene manipulation through the use of small interfering RNA (siRNA): From in vitro to in vivo applications

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid Nanoparticles as a Platform for miRNA and siRNA Delivery in Hepatocellular Carcinoma;Current Drug Delivery;2024-05-02

2. PEI, a new transfection method, augments the inhibitory effect of RBM5 on prostate cancer;Biochemical and Biophysical Research Communications;2024-04

3. An update on strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery: exploiting transformability and bioactivity of PLN and harnessing intracellular lipid transport mechanism;Expert Opinion on Drug Delivery;2024-02

4. A lipid–polymer hybrid nanoparticle (LPN)-loaded dissolving microneedle patch for promoting hair regrowth by transdermal miR-218 delivery;Biomaterials Science;2023

5. siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases;Pharmaceutics;2022-11-19